BioAgilytix announced that a global private investment firm, Cinven, will acquire a majority stake in the Durham-headquartered company that announced a $61.5 million investment in Durham last October.
Read More
BioAgilytix Labs is continuing to grow through acquisition, announcing Wednesday evening its second acquisition this week.
Read More
BioAgilytix will acquire the Australian firm 360biolabs® to expand its global footprint, as the company’s expansion in its Durham headquarters continues.
Read More
BioAgilytix, one of North Carolina’s fastest-growing home-grown life sciences companies, is adding 878 new employees with a $61.5 million investment in its global Durham headquarters.
Read More
Prior to joining BioAgilytix, Kennon Broadhurst served as Managing Partner at the Bilgola Group, which specializes in marketing and product commercialization consulting for the life science industry.
Read More
Fast-growing BioAgilytix, a provider of testing and bioanalysis services for life science firms, is expanding its footprint with the acquisition of Massachusetts-based Cambridge Biomedical.
Read More
Durham-based BioAgilytix, a fast-growing provider of bioanalytical testing services for large-molecule drugs, will be acquired by a privately held Belgian investment company.
Read More
During the past three years, the Raleigh-based consulting firm has grown 703 percent as entrepreneurs from around the world tap into the EGC’s expertise in identifying and managing grant funding.
Read More
